IRADIMED CORPORATION
US ˙ NasdaqGM ˙ US46266A1097

SecurityIRMD / IRADIMED CORPORATION
InstitutionRanger Investment Management, L.P.
Latest Disclosed Ownership111,085 shares
Latest Disclosed Value $ 10,693,042
Ranger Investment Management, L.P. reports 0.35% decrease in ownership of IRMD / IRADIMED CORPORATION

On May 15, 2026 - Ranger Investment Management, L.P. filed a 13F-HR form disclosing ownership of 111,085 shares of IRADIMED CORPORATION (US:IRMD) valued at $10,693,042 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 111,470 shares of IRADIMED CORPORATION. This represents a change in shares of -0.35% during the quarter. The current value of the position is $10,122,065 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F iRadimed COM 46266A109 111,085 -385 -0.35 10,693 -1.38 0.7737
2026-02-13 2025-12-31 13F iRadimed COM 46266A109 111,470 -8,150 -6.81 10,844 27.38 0.7438
2025-11-05 2025-09-30 13F iRadimed COM 46266A109 119,620 -95,220 -44.32 8,512 -33.73 0.5935
2025-08-19 2025-06-30 13F iRadimed COM 46266A109 214,840 14,730 7.36 12,845 22.32 0.8970
2025-05-15 2025-03-31 13F iRadimed COM 46266A109 200,110 -44,623 -18.23 10,502 -21.98 0.7505
2025-02-13 2024-12-31 13F iRadimed COM 46266A109 244,733 -5,409 -2.16 13,460 7.00 0.8498
2024-11-04 2024-09-30 13F iRadimed COM 46266A109 250,142 11,044 4.62 12,580 19.74 0.8072
2024-08-14 2024-06-30 13F iRadimed COM 46266A109 239,098 7,079 3.05 10,506 2.93 0.7148
2024-05-15 2024-03-31 13F iRadimed COM 46266A109 232,019 8,407 3.76 10,207 -3.84 0.6563
2024-02-14 2023-12-31 13F iRadimed COM 46266A109 223,612 11,465 5.40 10,615 12.77 0.6436
2023-11-14 2023-09-30 13F iRadimed COM 46266A109 212,147 -12,168 -5.42 9,413 -12.10 0.6250
2023-08-14 2023-06-30 13F iRadimed COM 46266A109 224,315 18,623 9.05 10,709 32.31 0.6445
2023-05-05 2023-03-31 13F iRadimed COM 46266A109 205,692 7,057 3.55 8,094 44.03 0.5424
2023-02-14 2022-12-31 13F iRadimed COM 46266A109 198,635 2,700 1.38 5,619 -4.60 0.4171
2022-11-14 2022-09-30 13F iRadimed COM 46266A109 195,935 -2,070 -1.05 5,890 -12.35 0.4624
2022-08-15 2022-06-30 13F iRadimed COM 46266A109 198,005 4,699 2.43 6,720 -22.47 0.5086
2022-05-13 2022-03-31 13F iRadimed COM 46266A109 193,306 11,570 6.37 8,668 3.22 0.5479
2022-02-11 2021-12-31 13F iRadimed COM 46266A109 181,736 -36,093 -16.57 8,398 14.77 0.4586
2021-11-15 2021-09-30 13F iRadimed COM 46266A109 217,829 2,107 0.98 7,317 15.34 0.3904
2021-08-16 2021-06-30 13F iRadimed COM 46266A109 215,722 -940 -0.43 6,344 13.63 0.3312
2021-05-17 2021-03-31 13F iRadimed COM 46266A109 216,662 -2,857 -1.30 5,583 11.55 0.3073
2021-02-12 2020-12-31 13F iRadimed COM 46266A109 219,519 -36,879 -14.38 5,005 -8.70 0.2639
2020-11-16 2020-09-30 13F iRadimed COM 46266A109 256,398 -6,025 -2.30 5,482 -10.00 0.3487
2020-08-14 2020-06-30 13F iRadimed COM 46266A109 262,423 27,111 11.52 6,091 21.24 0.4172
2020-05-15 2020-03-31 13F iRadimed COM 46266A109 235,312 -9,651 -3.94 5,024 -12.28 0.4420
2020-02-14 2019-12-31 13F iRadimed COM 46266A109 244,963 -39,627 -13.92 5,727 -4.26 0.3776
2019-11-14 2019-09-30 13F iRadimed COM 46266A109 284,590 10,628 3.88 5,982 6.76 0.4289
2019-08-14 2019-06-30 13F iRadimed COM 46266A109 273,962 11,050 4.20 5,603 -24.13 0.3819
2019-05-15 2019-03-31 13F iRadimed COM 46266A109 262,912 72,686 38.21 7,385 58.71 0.5340
2019-02-14 2018-12-31 13F iRadimed COM 46266A109 190,226 22,341 13.31 4,653 -25.40 0.3795
2018-11-14 2018-09-30 13F iRadimed COM 46266A109 167,885 -3,069 -1.80 6,237 75.84 0.4116
2018-08-14 2018-06-30 13F iRadimed COM 46266A109 170,954 42,904 33.51 3,547 96.40 0.2480
2018-05-15 2018-03-31 13F iRadimed COM 46266A109 128,050 112,353 715.76 1,806 658.82 0.1334
2018-02-13 2017-12-31 13F iRadimed COM 46266A109 15,697 15,697 238 0.0175
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.